Busulfan

CAS 55-98-1 9 current records 1 historicalSmall Molecule

Who holds supplier records for Busulfan? 9 organisations hold a current record for Busulfan: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), United States (2), Italy (1), Australia (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Busulfan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/busulfan

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Busulfan. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Busulfan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (7)

Certificates of Suitability on the EDQM register for Busulfan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
EMCURE PHARMACEUTICALS LIMITED PuneIN
CEP 2013-341 - Rev 02
Busulfan
Apr 2026—
FRESENIUS KABI ONCOLOGY LIMITED KalyaniIN
CEP 2010-374 - Rev 09
Busulfan
Sept 2025—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2018-265 - Rev 01
Busulfan
Feb 2025Inspected Jul 2026
Italy
APICORE US LLC SomersetUS
R1-CEP 2016-270 - Rev 00
Busulfan
May 2023—
SHIVALIK RASAYAN LIMITED New DelhiIN
R0-CEP 2021-356 - Rev 00
Busulfan
Dec 2022—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
R1-CEP 2011-339 - Rev 02
Busulfan
Jul 2022—
EXCELLA GMBH & CO. KG FeuchtDE
R1-CEP 2013-212 - Rev 00
Busulfan
Apr 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Busulfan are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Overview

Busulfan is a chemotherapy drug that acts as an alkylating agent, primarily used in bone marrow transplantation conditioning regimens. It helps destroy bone marrow and malignant cells in chronic myelogenous leukemia treatment.

Chemical identity

IUPAC name
4-methylsulfonyloxybutyl methanesulfonate
Canonical SMILES
CS(=O)(=O)OCCCCOS(=O)(=O)C
InChIKey
COVZYZSDYWQREU-UHFFFAOYSA-N
Synonyms
Myleran API, busilvex, busulfan fresenius kabi, busulfanum, busulfex, leucosulfan, myelosanum, nci-c01592, nsc-750, sulphabutin

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Alkylating Drug
Mechanism of action
Alkylating Activity

Therapeutic areas

OncologyHematology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Busulfan?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Busulfan: APICORE US LLC (United States), Emcure Pharmaceuticals Limited (India), Farmabios S.p.A. (Italy), SHILPA PHARMA LIFESCIENCES LTD (India), ARTHUR GROUP LLC (Australia), CHEMPACIFIC CORP (United States), EXCELLA GMBH AND CO KG (Germany) and FRESENIUS KABI ONCOLOGY LTD (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Busulfan Drug Master Files are active?

APICORE US LLC (DMF 23924), Emcure Pharmaceuticals Limited (DMF 25433), Farmabios S.p.A. (DMF 25933), SHILPA PHARMA LIFESCIENCES LTD (DMF 25491), ARTHUR GROUP LLC (DMF 25667) and CHEMPACIFIC CORP (DMF 21126). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Busulfan records mean?

1 organisation has only inactive Type II DMFs for Busulfan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Busulfan have a European Certificate of Suitability?

Yes. 7 organisations hold a valid CEP for Busulfan on the EDQM register, including EMCURE PHARMACEUTICALS LIMITED Pune (IN), FRESENIUS KABI ONCOLOGY LIMITED Kalyani (IN), FARMABIOS S.p.A Gropello Cairoli (IT), APICORE US LLC Somerset (US), SHIVALIK RASAYAN LIMITED New Delhi (IN) and SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Busulfan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Busulfan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.